ZAKTUDIS Trademark

Trademark Overview


On Friday, April 7, 2017, a trademark application was filed for ZAKTUDIS with the United States Patent and Trademark Office. The USPTO has given the ZAKTUDIS trademark a serial number of 87402579. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 17, 2024. This trademark is owned by Glaxo Group Limited. The ZAKTUDIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
zaktudis

General Information


Serial Number87402579
Word MarkZAKTUDIS
Filing DateFriday, April 7, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 17, 2024
Registration Number5328985
Registration DateTuesday, November 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Thursday, June 8, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, June 8, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 11, 2017NEW APPLICATION ENTERED
Friday, April 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 5, 2017ASSIGNED TO EXAMINER
Thursday, June 8, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2017ASSIGNED TO LIE
Tuesday, August 22, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017REGISTERED-PRINCIPAL REGISTER
Monday, November 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 8, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, June 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 17, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED